Pfizer, Warner Lambert settle with direct purchasers for $190 million in Neurontin antitrust case
( April 21, 2014, 20:13 GMT | Official Statement) -- MLex Summary: Pfizer and Warner Lambert have agreed to pay $190 million to settle allegations that the drugmakers conspired to delay generic entry of the drug Neurontin, plaintiffs' lawyers representing direct purchasers announced.Kaplan Fox Announces $190 Million Settlement with Pfizer, Inc. and Warner-Lambert Co....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.